Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Peripheral Blood Stem Cell Transplantation | 3 | 2012 | 67 | 1.130 |
Why?
|
| Autoantibodies | 4 | 2011 | 267 | 0.960 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2013 | 292 | 0.730 |
Why?
|
| Isoantibodies | 4 | 2010 | 114 | 0.690 |
Why?
|
| Hamartoma | 1 | 2017 | 31 | 0.590 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 79 | 0.550 |
Why?
|
| Erythrocyte Transfusion | 3 | 2013 | 60 | 0.530 |
Why?
|
| Plasma Exchange | 2 | 2011 | 29 | 0.500 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 2 | 2012 | 50 | 0.460 |
Why?
|
| Citric Acid | 1 | 2013 | 38 | 0.460 |
Why?
|
| Cell Separation | 1 | 2013 | 196 | 0.450 |
Why?
|
| Heparin | 1 | 2013 | 175 | 0.430 |
Why?
|
| Anemia, Sickle Cell | 2 | 2013 | 131 | 0.420 |
Why?
|
| Anti-N-Methyl-D-Aspartate Receptor Encephalitis | 1 | 2011 | 8 | 0.410 |
Why?
|
| Granulocytes | 1 | 2011 | 37 | 0.400 |
Why?
|
| Coombs Test | 2 | 2010 | 8 | 0.390 |
Why?
|
| Blood Group Antigens | 2 | 2007 | 17 | 0.380 |
Why?
|
| Anticoagulants | 1 | 2013 | 406 | 0.360 |
Why?
|
| Amyloidosis | 1 | 2011 | 115 | 0.350 |
Why?
|
| Lymphoma | 1 | 2011 | 262 | 0.340 |
Why?
|
| Erythrocytes | 2 | 2007 | 254 | 0.340 |
Why?
|
| Tissue Donors | 1 | 2012 | 465 | 0.340 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2009 | 165 | 0.340 |
Why?
|
| Age Factors | 2 | 2012 | 1828 | 0.330 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2014 | 931 | 0.320 |
Why?
|
| Blood Component Removal | 1 | 2008 | 24 | 0.320 |
Why?
|
| Blood Donors | 1 | 2008 | 26 | 0.320 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 737 | 0.300 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 40 | 0.300 |
Why?
|
| Multiple Myeloma | 1 | 2011 | 307 | 0.300 |
Why?
|
| Health Status | 1 | 2009 | 360 | 0.300 |
Why?
|
| Donor Selection | 1 | 2007 | 68 | 0.290 |
Why?
|
| Safety | 1 | 2007 | 151 | 0.290 |
Why?
|
| Microscopy | 1 | 2007 | 87 | 0.280 |
Why?
|
| Living Donors | 1 | 2009 | 339 | 0.280 |
Why?
|
| Colorectal Neoplasms | 1 | 2014 | 937 | 0.270 |
Why?
|
| Immunoglobulin G | 1 | 2007 | 457 | 0.250 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2014 | 2438 | 0.230 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 1054 | 0.200 |
Why?
|
| Transplantation, Homologous | 3 | 2012 | 996 | 0.180 |
Why?
|
| Female | 11 | 2017 | 44216 | 0.180 |
Why?
|
| Aged | 7 | 2015 | 18161 | 0.170 |
Why?
|
| Humans | 17 | 2017 | 85777 | 0.170 |
Why?
|
| Middle Aged | 9 | 2017 | 24740 | 0.170 |
Why?
|
| Hemolysis | 2 | 2010 | 61 | 0.170 |
Why?
|
| Adolescent | 4 | 2012 | 8959 | 0.160 |
Why?
|
| Male | 12 | 2015 | 40652 | 0.160 |
Why?
|
| Pemetrexed | 1 | 2015 | 76 | 0.130 |
Why?
|
| Drug Eruptions | 1 | 2015 | 33 | 0.130 |
Why?
|
| Liver Function Tests | 1 | 2014 | 93 | 0.120 |
Why?
|
| Bilirubin | 1 | 2014 | 125 | 0.120 |
Why?
|
| Organoplatinum Compounds | 1 | 2014 | 94 | 0.120 |
Why?
|
| Leucovorin | 1 | 2014 | 218 | 0.120 |
Why?
|
| Cetuximab | 1 | 2014 | 113 | 0.120 |
Why?
|
| Dexamethasone | 1 | 2015 | 326 | 0.110 |
Why?
|
| Hemoglobin, Sickle | 1 | 2013 | 19 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2015 | 350 | 0.110 |
Why?
|
| Body Weight | 2 | 2013 | 451 | 0.100 |
Why?
|
| Fluorouracil | 1 | 2014 | 555 | 0.100 |
Why?
|
| Catatonia | 1 | 2011 | 8 | 0.100 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 158 | 0.100 |
Why?
|
| Treatment Outcome | 3 | 2014 | 7830 | 0.100 |
Why?
|
| Hypocalcemia | 1 | 2011 | 41 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2011 | 283 | 0.100 |
Why?
|
| Young Adult | 3 | 2013 | 5961 | 0.100 |
Why?
|
| Illinois | 1 | 2012 | 462 | 0.090 |
Why?
|
| Laryngeal Edema | 1 | 2010 | 7 | 0.090 |
Why?
|
| Hemagglutinins | 1 | 2010 | 19 | 0.090 |
Why?
|
| Family | 1 | 2012 | 311 | 0.090 |
Why?
|
| Transfusion Reaction | 1 | 2010 | 15 | 0.090 |
Why?
|
| Acute Chest Syndrome | 1 | 2010 | 16 | 0.090 |
Why?
|
| Retrospective Studies | 4 | 2015 | 8456 | 0.090 |
Why?
|
| Death, Sudden | 1 | 2010 | 40 | 0.090 |
Why?
|
| Transplantation, Autologous | 1 | 2011 | 331 | 0.090 |
Why?
|
| Transplantation Conditioning | 1 | 2012 | 373 | 0.090 |
Why?
|
| Immunization | 1 | 2010 | 159 | 0.090 |
Why?
|
| Blood Cell Count | 1 | 2009 | 79 | 0.090 |
Why?
|
| Filgrastim | 1 | 2009 | 56 | 0.090 |
Why?
|
| HLA Antigens | 1 | 2011 | 232 | 0.090 |
Why?
|
| Fatal Outcome | 1 | 2010 | 295 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 1202 | 0.090 |
Why?
|
| Siblings | 1 | 2009 | 111 | 0.090 |
Why?
|
| Adult | 5 | 2013 | 25518 | 0.080 |
Why?
|
| Herpes Simplex | 1 | 2010 | 202 | 0.080 |
Why?
|
| Platelet Transfusion | 1 | 2008 | 14 | 0.080 |
Why?
|
| Lymphocyte Count | 1 | 2008 | 94 | 0.080 |
Why?
|
| Platelet Count | 1 | 2008 | 92 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2008 | 220 | 0.080 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 1677 | 0.080 |
Why?
|
| Blood Component Transfusion | 1 | 2007 | 13 | 0.080 |
Why?
|
| Splenic Rupture | 1 | 2007 | 7 | 0.080 |
Why?
|
| Recombinant Proteins | 1 | 2009 | 1018 | 0.080 |
Why?
|
| Agglutination | 1 | 2007 | 17 | 0.070 |
Why?
|
| Blood Group Incompatibility | 1 | 2007 | 18 | 0.070 |
Why?
|
| Edetic Acid | 1 | 2007 | 43 | 0.070 |
Why?
|
| Infant | 1 | 2013 | 3049 | 0.070 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2007 | 71 | 0.070 |
Why?
|
| Spleen | 1 | 2007 | 430 | 0.070 |
Why?
|
| Comorbidity | 1 | 2009 | 912 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1561 | 0.070 |
Why?
|
| Heart Transplantation | 1 | 2011 | 705 | 0.070 |
Why?
|
| Graft Rejection | 1 | 2011 | 1065 | 0.060 |
Why?
|
| Algorithms | 1 | 2013 | 1824 | 0.060 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2007 | 261 | 0.060 |
Why?
|
| Pneumonia, Viral | 1 | 2010 | 315 | 0.060 |
Why?
|
| Prognosis | 1 | 2012 | 3639 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 2360 | 0.060 |
Why?
|
| Child, Preschool | 1 | 2010 | 3612 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 1655 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3366 | 0.050 |
Why?
|
| Leukocyte Reduction Procedures | 1 | 2013 | 3 | 0.030 |
Why?
|
| Hematocrit | 1 | 2013 | 67 | 0.030 |
Why?
|
| Automation | 1 | 2013 | 106 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2011 | 98 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 2010 | 23 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2010 | 129 | 0.020 |
Why?
|
| Myocardium | 1 | 2011 | 550 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2010 | 364 | 0.020 |
Why?
|
| Length of Stay | 1 | 2010 | 704 | 0.020 |
Why?
|
| Calcium | 1 | 2011 | 1152 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 1075 | 0.020 |
Why?
|
| Anemia | 1 | 2007 | 124 | 0.020 |
Why?
|
| Incidence | 1 | 2010 | 1543 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 2261 | 0.010 |
Why?
|
| Time Factors | 1 | 2011 | 5178 | 0.010 |
Why?
|
| Child | 1 | 2013 | 6930 | 0.010 |
Why?
|